SPHERA FUNDS MANAGEMENT LTD. - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 103 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2016$1,840,000
-48.3%
400,000
-41.6%
0.40%
-23.6%
Q4 2015$3,562,000
+0.8%
685,000
+17.3%
0.52%
+15.7%
Q3 2015$3,534,000
+8.4%
584,089
+182.9%
0.45%
+41.4%
Q2 2015$3,261,000206,5000.32%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders